Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke

Abraha, 1997, Serum S-100 protein, relationship to clinical outcome in acute stroke, Ann Clin Biochem, 34, 366, 10.1177/000456329703400405

Fassbender, 1997, Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke, J Neurol Sci, 148, 101, 10.1016/S0022-510X(96)05351-8

Missler, 1997, S-100 protein and neuron-specific enolase concentrations in blood as indicator of stroke volume, Stroke, 28, 1956, 10.1161/01.STR.28.10.1956

Büttner, 1997, S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction, Stroke, 28, 1961, 10.1161/01.STR.28.10.1961

Wunderlich, 1999, Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage, Stroke, 30, 1190, 10.1161/01.STR.30.6.1190

Wunderlich, 2004, Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke, J Neurol Sci, 227, 49, 10.1016/j.jns.2004.08.005

Foerch, 2003, S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion, J Neurol Neurosurg Psychiatry, 74, 322, 10.1136/jnnp.74.3.322

Foerch, 2005, Evaluation o serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction, Arch Neurol, 62, 1130, 10.1001/archneur.62.7.1130

Barone, 1993, Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia, Brain Res, 623, 77, 10.1016/0006-8993(93)90012-C

Cunningham, 1991, Serum neuron-specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction, Eur J Clin Invest, 21, 497, 10.1111/j.1365-2362.1991.tb01401.x

Oh, 2003, Prediction of early clinical severity and extent of neuronal damage in anterior-circulation infarction using the initial serum neuron-specific enolase level, Arch Neurol, 60, 37, 10.1001/archneur.60.1.37

Schaarschmidt, 1994, Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases, Stroke, 25, 558, 10.1161/01.STR.25.3.558

Butterworth, 1996, Serum neuron-specific enolase, carnosinase, and their ratio in acute stroke. An enzymatic test for outcome prediction?, Stroke, 27, 2064, 10.1161/01.STR.27.11.2064

Anand, 2005, Neuron-specific enolase as a marker for acute ischemic stroke: a systematic review, Cerebrovasc Dis, 20, 213, 10.1159/000087701

Otto, 2003, Differential diagnosis of neurodegenerative diseases with special emphasis on Creutzfeldt–Jakob disease, Restor Neurol Neurosci, 21, 191

Franz, 2003, Amyloid beta 1–42 and tau in cerebrospinal fluid after severe traumatic brain injury, Neurology, 60, 1457, 10.1212/01.WNL.0000063313.57292.00

Shiiya, 2004, Tau protein in the cerebrospinal fluid is a marker of brain injury after aortic surgery, Ann Thorac Surg, 77, 2034, 10.1016/j.athoracsur.2003.12.057

Hesse, 2000, Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke, J Alzheimers Dis, 2, 199, 10.3233/JAD-2000-23-402

Bitsch, 2002, Serum Tau protein level as a marker of axonal damage in acute ischemic stroke, Eur Neurol, 47, 45, 10.1159/000047946

Casmiro, 2005, Cerebrospinal fluid and serum neuron-specific enolase concentrations in a normal population, Eur J Neurol, 12, 369, 10.1111/j.1468-1331.2004.01021.x

Zanette, 1989, Comparison of cerebral angiography and transcranial Doppler sonography in acute stroke patients, Stroke, 20, 899, 10.1161/01.STR.20.7.899

Burgin, 2000, Alexandrov AV: transcranial Doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke, Stroke, 31, 1128, 10.1161/01.STR.31.5.1128

Lyden, 1994, Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group, Stroke, 25, 2220, 10.1161/01.STR.25.11.2220

van Swieten, 1988, Interobserver agreement for the assessment of handicap in stroke patients, Stroke, 19, 604, 10.1161/01.STR.19.5.604

Mahoney, 1965, Functional evaluation: the Barthel index, Md State Med J, 14, 61

Adams, 1993, Classification of subtype of acute ischemic stroke, Stroke, 24, 35, 10.1161/01.STR.24.1.35

Stevens, 1999, Neuron-specific enolase and N-acetyl-aspartate as potential peripheral markers of ischaemic stroke, Eur J Clin Invest, 29, 6, 10.1046/j.1365-2362.1999.00408.x

Hardemark, 1989, S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage, J Neurosurg, 71, 727, 10.3171/jns.1989.71.5.0727

Hatfield, 1992, CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat model, Brain Res, 577, 249, 10.1016/0006-8993(92)90280-M

Hill, 2000, Biochemical markers in acute ischemic stroke, CMAJ, 162, 1139

Reiber, 2003, Proteins in cerebrospinal fluid and blood: Barriers. CSF flow rate and source-related dynamics, Restor Neurol Neurosci, 21, 79

Marchi, 2004, Peripheral markers of the blood-brain barrier damage, Clin Chim Acta, 342, 1, 10.1016/j.cccn.2003.12.008